Tisotumab Vedotin vs. Investigator’s Choice in Cervical Cancer – ESMO 2023 Cervical 3 Mins Read4 By. Brian SlomovitzDate. October 26, 2023 Brian Slomovitz, MD, presented insights into the innovaTV 301 study and its implications for…
